Diaphanous-related formin 1 as a target for tumor therapy

Yuan-Na Lin1,2, Sabine Windhorst2

  • 1Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany.

Insights

Formins are proteins that stabilize microtubules (MTs) in cancer cells. Lowering DIAPH formin expression may increase cancer cell sensitivity to taxane drugs, suggesting a new therapeutic strategy.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Microtubule Dynamics

Background:

  • Formins are proteins that nucleate actin filaments and stabilize microtubules (MTs).
  • Specific formins, DIAPH1 and DIAPH3, are upregulated in colon, breast, and prostate carcinomas and stabilize interphase MTs.
  • DIAPH2 regulates metaphase MTs by stabilizing kinetochore-chromosome interactions, crucial for proper mitosis.

Purpose of the Study:

  • To investigate the role of DIAPH formins in cancer cell biology.
  • To explore the potential of targeting DIAPH formins for cancer therapy, particularly in relation to taxane sensitivity.

Main Methods:

  • Analysis of DIAPH1, DIAPH2, and DIAPH3 expression in various carcinoma cells.
  • Investigating the function of DIAPH formins in stabilizing interphase and metaphase microtubules.
  • Assessing the impact of DIAPH formin depletion on cancer cell metastasis and sensitivity to taxanes.

Main Results:

  • DIAPH1 and DIAPH3 stabilize interphase MTs in cancer cells; their depletion reduces metastatic potential.
  • DIAPH3 depletion enhances the sensitivity of breast and prostate cancer cells to taxanes.
  • DIAPH2 stabilizes MTs at kinetochores, and its depletion impairs chromosome segregation during mitosis.

Conclusions:

  • DIAPH formins play critical roles in stabilizing MTs in both interphase and mitosis within tumor cells.
  • Tumor cells with low DIAPH expression may exhibit increased sensitivity to taxane-based chemotherapy.
  • Targeting DIAPH formins could represent a novel therapeutic strategy to overcome taxane resistance in cancer.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K